Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference May 19, 2026
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights May 14, 2026
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights May 13, 2026
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 May 06, 2026
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference May 04, 2026
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million Mar 30, 2026
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights Mar 25, 2026
